These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 12074212

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pneumococcal conjugate vaccine for young children.
    Selman S, Hayes D, Perin LA, Hayes WS.
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [Abstract] [Full Text] [Related]

  • 3. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
    Kilpi T, Ahman H, Jokinen J, Lankinen KS, Palmu A, Savolainen H, Grönholm M, Leinonen M, Hovi T, Eskola J, Käyhty H, Bohidar N, Sadoff JC, Mäkelä PH, Finnish Otitis Media Study Group.
    Clin Infect Dis; 2003 Nov 01; 37(9):1155-64. PubMed ID: 14557958
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ, Vermeiren JS, Vaneechoutte M, Claeys G, Veenhoven RH, Rijkers GT, Sanders EA, Dhooge IJ.
    Int J Pediatr Otorhinolaryngol; 2006 Feb 01; 70(2):275-85. PubMed ID: 16140397
    [Abstract] [Full Text] [Related]

  • 6. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
    Haveman LM, Geelen SP, Sanders EA, Wolfs TF.
    Ned Tijdschr Geneeskd; 2002 Oct 12; 146(41):1917-20. PubMed ID: 12404904
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
    Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkelä PH, Finnish Otitis Media Study Group.
    N Engl J Med; 2001 Feb 08; 344(6):403-9. PubMed ID: 11172176
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.
    O'Brien KL, Moisi J, Moulton LH, Madore D, Eick A, Reid R, Weatherholtz R, Millar E, Hu D, Hackell J, Kohberger R, Siber G, Santosham M.
    J Infect Dis; 2007 Jul 01; 196(1):104-14. PubMed ID: 17538890
    [Abstract] [Full Text] [Related]

  • 11. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population.
    Millar EV, O'Brien KL, Watt JP, Bronsdon MA, Dallas J, Whitney CG, Reid R, Santosham M.
    Clin Infect Dis; 2006 Jul 01; 43(1):8-15. PubMed ID: 16758412
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR.
    Laryngorhinootologie; 2006 Apr 01; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [Abstract] [Full Text] [Related]

  • 14. Prevnar (heptavalent pneumococcal conjugate vaccine): disease prevention in infants and children.
    Shields B.
    J Pediatr Health Care; 2001 Apr 01; 15(4):203-8; quiz 209-10. PubMed ID: 11462129
    [No Abstract] [Full Text] [Related]

  • 15. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.
    Dagan R, Givon-Lavi N, Shkolnik L, Yagupsky P, Fraser D.
    J Infect Dis; 2000 Apr 01; 181(4):1322-9. PubMed ID: 10753730
    [Abstract] [Full Text] [Related]

  • 16. The pneumococcal conjugate vaccine.
    Jacobson RM, Poland GA.
    Minerva Pediatr; 2002 Aug 01; 54(4):295-303. PubMed ID: 12131865
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
    Reinert P, Benkerrou M, de Montalembert M, Lesprit E, Abadie I, Bernaudin F, Doit C, Bingen E, Tetelboum R, Bonnet E.
    Pediatr Infect Dis J; 2007 Dec 01; 26(12):1105-9. PubMed ID: 18043446
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 01; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [Abstract] [Full Text] [Related]

  • 20. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R, Levy C, de La Rocque F, Gelbert N, Wollner A, Fritzell B, Bonnet E, Tetelboum R, Varon E.
    Pediatr Infect Dis J; 2006 Nov 01; 25(11):1001-7. PubMed ID: 17072121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.